University Hospitals’ Seidman Cancer Center has received a $3.5 million gift to support efforts to triple capacity for clinical trials within the next five years. The gift comes from Kathy Coleman, who has donated more than $14 million to the…
Oncology
Despite breakthroughs in drug therapies and diagnostic technologies, prostate cancer incidence in the U.S. has increased 3.0% per year. At the same time, prostate cancer mortality is declining at a slower rate than the previous two decades. As chief clinical…
A urine-based biomarker panel detected prostate cancer in 91% of specimens with a diagnostic accuracy of 78.6% to 85.7%, according to a study published Sept. 2 in eBioMedicine. Led by a team from Baltimore-based Johns Hopkins Kimmel Cancer Center and…
Columbus-based Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has launched a fully remote clinical trial for pancreatic cancer patients across the U.S. Led by Sameek Roychowdhury, MD, PhD, an oncologist at…
Following almost a decade of decline, prostate cancer incidence in the U.S. increased 3.0% per year between 2014 through 2021, according to a report published Sept. 2 in CA: A Cancer Journal for Clinicians. Incidence of advanced-stage prostate cancer at…
Advertisement
Evanston, Ill.-based Endeavor Health is in the midst of executing a $181 million expansion plan. An integral part of which is integrating its newly launched Endeavor Health Cancer Institute across the nine-hospital system. At the helm of this integration are…
A former researcher at Houston-based University Texas of MD Anderson has been charged with theft of trade secrets and tampering with a government record, according to an Aug. 25 report from the Houston Chronicle. The researcher, Yunhai Li, PhD, was…
Led by a team from Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center, researchers have created the largest and most detailed profile of genetic mutations found in African American women with triple-negative breast cancer. The team’s study was published Aug. 26…
Cancer-induced nerve injury, a cause of chronic inflammation, may lead to immunotherapy resistance, according to a study published Aug. 20 in Nature. The research was led by teams from Houston-based University of Texas MD Anderson Cancer Center and Tampa, Fla.-based…
A history of traumatic brain injury may be associated with an increased risk of developing a malignant brain tumor, according to a study published Aug. 25 in JAMA Network Open. Led by a team from Somerville, Mass.-based Mass General Brigham,…